Dwarfism Clinical Trial
Official title:
Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Idiopathic Short Stature: A Controlled, Prospective, Randomized, Multicenter Phase-II Study With An Untreated Control Group.
This study aims to explore the optimal dose of pegylated recombinant human growth hormone (PEG-rhGH) injection to treat children with idiopathic short stature (ISS), evaluate its safety and efficacy, and provide scientific and reliable evidence for the medication dosage in Phase III clinical study.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01157793 -
A Multicentre, Randomised, Open-label, Controlled Study to Evaluate the Effects of Saizen® on Cardiac Function in Growth Hormone Deficient(GHD) Subjects During the Transition Phase From Childhood to Adulthood
|
Phase 4 | |
| Completed |
NCT00001190 -
Study of Luteinizing Hormone-Releasing Hormone Analog (LHRHa) in Pubertal Patients With Extreme Short Stature
|
Phase 2 | |
| Active, not recruiting |
NCT03255694 -
A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of Children With Idiopathic Short Stature
|
Phase 2 | |
| Recruiting |
NCT03535415 -
A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Short Stature Children Due to Chronic Kidney Disease Before Transplantation
|
Phase 3 | |
| Completed |
NCT00234533 -
Study to Define Optimal IGF-1 Monitoring in Children Treated With NutropinAq
|
Phase 3 | |
| Completed |
NCT00001754 -
Study of Skeletal Disorders and Short Stature
|
N/A | |
| Recruiting |
NCT03635580 -
Efficacy and Safety of rhGH (Jintropin®) in Pediatric Participants With ISS
|
Phase 3 | |
| Completed |
NCT00001343 -
The Effects of Hormones in Growth Hormone-Treated Girls With Turner Syndrome
|
Phase 2 | |
| Completed |
NCT00001536 -
Issues Surrounding Prenatal Genetic Testing for Achondroplasia
|
N/A |